BR112015022473A2 - método e sistema para prever a resposta a tratamentos contra a dor - Google Patents
método e sistema para prever a resposta a tratamentos contra a dorInfo
- Publication number
- BR112015022473A2 BR112015022473A2 BR112015022473A BR112015022473A BR112015022473A2 BR 112015022473 A2 BR112015022473 A2 BR 112015022473A2 BR 112015022473 A BR112015022473 A BR 112015022473A BR 112015022473 A BR112015022473 A BR 112015022473A BR 112015022473 A2 BR112015022473 A2 BR 112015022473A2
- Authority
- BR
- Brazil
- Prior art keywords
- response
- individual
- pain
- predicting
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
“método e sistema para prever a resposta a tratamentos contra a dor” resumo a presente invenção refere-se a sistemas e métodos para prever a resposta provável de um indivíduo de uma medicação para a dor compreendendo a genotipagem de variações genéticas em que um indivíduo para determinar a propensão do indivíduo pela metabolização de uma medicação para a dor e a resposta provável a um medicamento, e de preferência diversas reacções a um medicamento. em particular, o invento compreende a análise de uma amostra biológica é fornecida por uma pessoa, tipicamente um paciente ou de um indivíduo diagnosticado com um distúrbio particular, a determinação da resposta provável do indivíduo a um determinado tratamento, mais especificamente uma medicação para a dor, e em seguida visualizadas, ou ainda mais, recomendando um plano de ação ou inação. em particular, a presente invenção proporciona um método de classificação e sistema de perfil de resposta de um indivíduo com uma ou mais medicação para a dor. 1/1
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361800506P | 2013-03-15 | 2013-03-15 | |
US201361800560P | 2013-03-15 | 2013-03-15 | |
US13/917,509 US20140274763A1 (en) | 2013-03-15 | 2013-06-13 | Method and system to predict response to pain treatments |
PCT/US2014/024939 WO2014151081A1 (en) | 2013-03-15 | 2014-03-12 | Method and system to predict response to pain treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015022473A2 true BR112015022473A2 (pt) | 2017-07-18 |
Family
ID=51529821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015022473A BR112015022473A2 (pt) | 2013-03-15 | 2014-03-12 | método e sistema para prever a resposta a tratamentos contra a dor |
Country Status (5)
Country | Link |
---|---|
US (3) | US20140274763A1 (pt) |
EP (1) | EP2973131A4 (pt) |
BR (1) | BR112015022473A2 (pt) |
HK (1) | HK1220520A1 (pt) |
WO (1) | WO2014151081A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140244556A1 (en) * | 2013-02-27 | 2014-08-28 | Abdul Saleh | Methods for and apparatus generating automated pharmaco genetics correlation |
US20160224754A1 (en) * | 2015-01-30 | 2016-08-04 | Elly Hann | Systems and methods for an interactive assessment and display of drug toxicity risks |
WO2016176519A1 (en) * | 2015-04-28 | 2016-11-03 | Proove Biosciences, Inc. | System and method for processing genotype information relating to drug metabolism |
CN107273710A (zh) * | 2017-08-22 | 2017-10-20 | 北京岙特杰诺生物科技有限公司 | 一种建立药物代谢酶基因与药物代谢的关系模型的方法 |
CN107893114A (zh) * | 2017-12-29 | 2018-04-10 | 韩林志 | 用于指导芬太尼类药物个体化用药相关基因检测的引物对、试剂盒及方法 |
JP6893052B1 (ja) * | 2020-06-29 | 2021-06-23 | ゲノム・ファーマケア株式会社 | 投与計画提案システム、方法およびプログラム |
CN112553325B (zh) * | 2020-12-29 | 2024-08-13 | 广东南芯医疗科技有限公司 | 舒芬太尼个体化用药基因的指导方法及试剂盒 |
EP4326904A2 (en) * | 2021-05-25 | 2024-02-28 | The Regents of the University of Colorado, a body corporate | Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in individuals diagnosed with alcohol use disorder |
CN113584161A (zh) * | 2021-06-15 | 2021-11-02 | 湖南菲思特精准医疗科技有限公司 | 一种芬太尼代谢标志物的检测试剂盒及其检测方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002090994A2 (en) * | 2001-05-07 | 2002-11-14 | Mcgill University | Individualization of therapy with analgesics |
WO2003008637A2 (en) * | 2001-07-17 | 2003-01-30 | Xanthus Life Sciences, Inc. | Use of genotyping in the individualization of therapy |
WO2005038049A2 (en) * | 2003-10-06 | 2005-04-28 | Heinrich Guenther | System and method for optimizing drug therapy |
AU2006205571B2 (en) * | 2005-01-13 | 2012-03-22 | Progenika Biopharma, S.A. | Methods and products for in vitro genotyping |
EP3703058A1 (en) * | 2005-11-29 | 2020-09-02 | Children's Hospital Medical Center | A method of selecting a medication for a patient |
GB0614396D0 (en) * | 2006-07-20 | 2006-08-30 | Knox Geoffrey M | Test for the presence of active CYP450 2D6 |
CA2671267A1 (en) * | 2006-11-30 | 2008-06-05 | Navigenics Inc. | Genetic analysis systems and methods |
CN101376908B (zh) * | 2007-08-29 | 2012-01-25 | 中国科学院大连化学物理研究所 | 一种基于分子和细胞水平研究药物代谢的方法 |
EP2381834A2 (en) * | 2008-01-31 | 2011-11-02 | Fund for Medical Research Development of Infrastructure & Health Services Rambam Medical Center | Method of predicting pain medication efficacy |
US7736861B1 (en) * | 2009-10-19 | 2010-06-15 | Aveo Pharmaceuticals, Inc. | Tivozanib response prediction |
US9558320B2 (en) * | 2009-10-26 | 2017-01-31 | Genomas, Inc. | Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants |
EP2785874B1 (en) * | 2011-11-30 | 2018-09-26 | Children's Hospital Medical Center | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
-
2013
- 2013-06-13 US US13/917,509 patent/US20140274763A1/en not_active Abandoned
-
2014
- 2014-03-12 WO PCT/US2014/024939 patent/WO2014151081A1/en active Application Filing
- 2014-03-12 BR BR112015022473A patent/BR112015022473A2/pt not_active Application Discontinuation
- 2014-03-12 EP EP14770061.1A patent/EP2973131A4/en not_active Withdrawn
-
2016
- 2016-04-29 US US15/143,100 patent/US20170051349A1/en not_active Abandoned
- 2016-07-14 HK HK16108292.0A patent/HK1220520A1/zh unknown
-
2017
- 2017-03-16 US US15/461,194 patent/US20170247760A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140274763A1 (en) | 2014-09-18 |
WO2014151081A1 (en) | 2014-09-25 |
US20170247760A1 (en) | 2017-08-31 |
EP2973131A1 (en) | 2016-01-20 |
EP2973131A4 (en) | 2017-03-15 |
HK1220520A1 (zh) | 2017-05-05 |
US20170051349A1 (en) | 2017-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015022473A2 (pt) | método e sistema para prever a resposta a tratamentos contra a dor | |
Magnavita et al. | Sleep, health and wellness at work: a scoping review | |
National Collaborating Centre for Mental Health (UK | Self-harm: longer-term management | |
BR112015022472A2 (pt) | método e sistema para prever a resposta a tratamentos para transtornos mentais | |
Wideman et al. | Reducing catastrophic thinking associated with pain | |
BR102013002579A8 (pt) | métodos, sistemas e produtos de programa baseados na localização para execução de uma ação no dispositivo de um usuário | |
BR112017006219A2 (pt) | sistema de controle para controle de distribuição de medicamentos | |
Miller et al. | The immunology of behavior—Exploring the role of the immune system in brain health and illness | |
BR112012020101A2 (pt) | método diagnósticos e terapêuticos usando anticorpos anti-cd200. | |
BR112014018433A8 (pt) | Métodos para determinar o período circadiano em um indivíduo humano e um tau de um paciente, para tratar um paciente humano, para fornecer informação relativa a um ritmo circadiano do paciente, e para converter dados da concentração de melatonina ou substituto de melantonina nos dados do ritmo circadiano, sistema, e, meio de armazenagem legível por computador | |
AU2018272076A1 (en) | Products and methods for therapeutic administration of microorganisms to non-human animals | |
BR112015030099A2 (pt) | marcador para desordens de esfingomielinase ácida e usos do mesmo | |
WO2012145499A3 (en) | System and method for medical messaging | |
Pawar | Level of stress among the nurses working in Intensive care units | |
Garg et al. | Exacerbation of auditory verbal hallucinations with adjunctive high-frequency cerebellar vermal repetitive transcranial magnetic stimulation in schizophrenia: a case report | |
ÇALIŞKAN et al. | Illness perception of the patients with hematological cancers: A single center study | |
Jurcik et al. | Chronic pain, negative affect, and prescription opioid abuse | |
BR112015024516A2 (pt) | métodos para identificar pacientes em risco de rejeição resistente ao bloqueio de coestimulação | |
BR112014019274A2 (pt) | métodos relacionados ao tratamento de doenças e distúrbios inflamatórios | |
Machfudz | Quality of life epilepsy in childhood: Comparison between well-controlled epilepsy and non epilepsy | |
Oniz et al. | An examination of behavioral odor data in sensory disabled individuals | |
Titov et al. | Improving Adherence and Clinical Outcomes in Self-Guided Internet Treatment for | |
De Taeye et al. | Preserved attention allocation but impaired emotion regulation in epilepsy with comorbid negative affect: electrophysiological time course | |
Patterson et al. | Diabetes and mental health: a holistic approach is needed | |
Poodineh et al. | Investigating the Effect of Muscular Relaxation Technique on Sleep Quality in Children with Leukemia Treated with Chemotherapy in Educational Hospitals of Zahedan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |